A new era for oral peptides: Snac and the development of oral semaglutide for the treatment of type 2 diabetes
Neuroprotective Properties Under Investigation The Zagreb groups 2016 review in Current Neuropharmacology described peripheral BPC-157 administration altering serotonin synthesis rates in specific brain regions, particularly nigrostriatal and other dopaminergic pathways (Tohyama, Sikiric, Diksic, 2004, Life Sciences )
0.01% w/v sodium citrate 0.008% w/v, and benzyl alcohol 1.0% v/v (preservative).
It influences sleep through several interconnected pathways: Delta wave enhancement: DSIP increases the amplitude and duration of delta waves during Stage 3 NREM sleep, extending the most restorative phase of sleep Circadian rhythm modulation: DSIP interacts with the body's internal clock mechanisms, helping to normalize disrupted sleep-wake patterns Cortisol regulation: DSIP has been shown to modulate cortisol secretion patterns, reducing the elevated nighttime cortisol that disrupts sleep in stressed individuals Serotonin pathway involvement: DSIP influences serotonergic neurotransmission, which plays a role in sleep onset and maintenance Stress buffering: By reducing the physiological stress response, DSIP helps create the neurochemical conditions favorable for sleep initiation and maintenance Research by Schneider-Helmert and Schoenenberger demonstrated that DSIP administration improved sleep quality in patients with chronic insomnia, with particular improvement in sleep onset latency and time spent in deep sleep stages.[2] Clinical Evidence Chronic Insomnia Studies Clinical studies have shown that DSIP improves multiple sleep parameters in patients with chronic insomnia, including reduced time to fall asleep, increased total sleep time, and improved subjective sleep quality ratings.[2] Stress-Related Sleep Disruption DSIP has demonstrated particular efficacy in stress-related sleep disturbances
Goulding et al., 2021
